Arkolith/Insider Trading/YMTX/Form 4

Peters Richard

President and CEO, DirectorYUMANITY THERAPEUTICS, INC. (YMTX) · full profile →Form 4 · filed Mar 30, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2022Sell(S)11K$1.85$20K116K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-012782) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML